FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
18/6/746
03-0475fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Z.
Right arrow Articles by Chan, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Z.
Right arrow Articles by Chan, C.
The FASEB Journal Express Article doi:10.1096/fj.03-0475fje
Published online February 6, 2004

Inferring pathways and networks with a Bayesian framework

Zheng Li and Christina Chan

E-mail contact: krischan{at}egr.msu.edu

Numerous mathematical methods have been adapted and developed to quantitatively reverse engineer biological networks, for example, signal transduction pathways, from experimental micro-array data. Compared with stochastic methods, such as Boolean networks, and deterministic methods, such as thermodynamic or differential equation-based models, Bayesian network analysis has the ability to assess, with scoring metrics, causal relations based on conditional probabilities and thus permit hypothesis testing. The goal of this paper is to illustrate the integration of several Bayesian based techniques into a unified Bayesian framework that can infer hepatocellular networks from metabolic data. Reverse engineering of pathways and networks provides a framework for predictive modeling and hypotheses testing to gain deeper insight into living organisms, disease mechanisms, and targeted therapeutics. Evaluating this methodology initially against the known biochemical network provides confidence in the networks that are uncovered from the experimental data using this framework. From the metabolic data we inferred the known sub-networks, such as the tricarboxylic acid (TCA) and urea cycles. In addition, we combined the relationships learned from the data and our current knowledge of the biological system to postulate several alternative metabolic sub-network models that can predict a particular cellular function, such as intracellular triglyceride accumulation.

Key words: reverse engineering • metabolic network • Bayesian network analysis • hepatocytes




This article has been cited by other articles:


Home page
Toxicol SciHome page
D. R. Boverhof and T. R. Zacharewski
Toxicogenomics in Risk Assessment: Applications and Needs
Toxicol. Sci., February 1, 2006; 89(2): 352 - 360.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
G. V. HarshaRani, S. J. Vayttaden, and U. S. Bhalla
Electronic Data Sources for Kinetic Models of Cell Signaling
J. Biochem., June 1, 2005; 137(6): 653 - 657.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Li, L. Lu, K. F. Manly, E. J. Chesler, L. Bao, J. Wang, M. Zhou, R. W. Williams, and Y. Cui
Inferring gene transcriptional modulatory relations: a genetical genomics approach
Hum. Mol. Genet., May 1, 2005; 14(9): 1119 - 1125.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Li and C. Chan
Integrating Gene Expression and Metabolic Profiles
J. Biol. Chem., June 25, 2004; 279(26): 27124 - 27137.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by The Federation of American Societies for Experimental Biology.